Amyloidosis – Life with Disease

Go back

Amyloidosis is a rare group of diseases where abnormal proteins fold incorrectly and build up in organs and tissues, potentially causing serious damage throughout the body.

Understanding Prognosis in Amyloidosis

Learning about the outlook for amyloidosis can be one of the most difficult conversations you’ll have with your doctor. The reality is that prognosis varies greatly depending on which type of amyloidosis you have, which organs are affected, and how early the disease is caught and treated. It’s important to remember that every person’s journey is different, and understanding your specific situation can help you and your loved ones prepare for what lies ahead.[1][2]

For AL amyloidosis, which is the most common type, the prognosis depends heavily on how much the heart and kidneys have been damaged by amyloid deposits. When these organs are significantly affected, the outlook becomes more serious. However, advances in treatment over recent years have offered new hope. Healthcare providers use staging systems that look at specific markers in your blood to help predict outcomes and guide treatment decisions. The earlier AL amyloidosis is diagnosed and treated, the better the chances of slowing or stopping the disease’s progression.[9][12]

ATTR amyloidosis, which includes both hereditary and wild-type forms, generally has a less aggressive course than AL amyloidosis. Wild-type ATTR amyloidosis typically affects older men and progresses more slowly. The hereditary forms can vary widely depending on the specific genetic mutation involved. Some people with hereditary ATTR may have symptoms that progress over many years, while others may experience faster deterioration. The good news is that new treatments specifically designed for ATTR amyloidosis have become available in recent years, offering patients better quality of life and improved survival.[2][5]

AA amyloidosis, which develops in people with chronic inflammatory conditions, has an outlook that is closely tied to controlling the underlying disease causing inflammation. When the inflammatory condition is well-managed, the production of amyloid proteins can slow down significantly, and in some cases, existing deposits may even begin to break down. This means that working closely with your doctors to control conditions like rheumatoid arthritis or chronic infections can have a real impact on your amyloidosis prognosis.[3][5]

⚠️ Important
Statistics about survival and prognosis are based on large groups of people and cannot predict what will happen to any individual person. Your specific outlook depends on your unique situation, including your overall health, the type of amyloidosis, how your body responds to treatment, and many other factors. Always discuss your personal prognosis with your healthcare team, who know your case best.

One of the challenges with amyloidosis is that diagnosis is often delayed because early symptoms can be vague and similar to many other, more common conditions. Research shows that around 70% of patients do not receive their diagnosis until more than a year after symptoms begin, and up to 20% may not be correctly diagnosed for two years or longer. This delay can allow more amyloid to accumulate in organs, making treatment more difficult and affecting long-term outcomes. That’s why early detection and prompt treatment are so critical.[15]

Natural Progression of Amyloidosis Without Treatment

If amyloidosis goes untreated, the abnormal proteins continue to be produced and accumulate in various organs throughout the body. This is a progressive process, meaning it generally gets worse over time rather than staying stable or improving on its own. The speed at which amyloidosis progresses varies greatly from person to person and depends on the type of amyloidosis and which organs are involved.[1][6]

In AL amyloidosis, abnormal plasma cells in the bone marrow continuously produce misfolded light chain proteins. These proteins circulate in the bloodstream and gradually deposit in tissues. Without treatment to stop this production, the amyloid deposits grow larger and interfere more severely with organ function. The heart is particularly vulnerable; as amyloid builds up in the heart muscle and surrounding tissues, the heart becomes stiffer and less able to pump blood effectively. This can lead to progressive heart failure. Similarly, when amyloid accumulates in the kidneys, they become less efficient at filtering waste from the blood, eventually leading to kidney failure.[2][9]

The natural course of ATTR amyloidosis is typically slower than AL amyloidosis, but it still leads to significant problems if left untreated. In wild-type ATTR amyloidosis, normal transthyretin protein produced by the liver slowly converts into amyloid over many years. This primarily affects the heart, causing it to gradually thicken and stiffen. People may first notice shortness of breath with activity, fatigue, or swelling in their legs, and these symptoms worsen over time as more amyloid accumulates. In hereditary ATTR amyloidosis, the abnormal transthyretin protein is more prone to forming amyloid, and the disease can affect both the heart and nerves, leading to progressive nerve damage alongside heart problems.[2][8]

AA amyloidosis develops when chronic inflammation causes the liver to produce high levels of serum amyloid A protein. Without treating the underlying inflammatory condition, this protein continues to be made and forms amyloid deposits, most commonly in the kidneys. Over time, untreated AA amyloidosis can lead to kidney failure requiring dialysis. The disease can also affect the digestive system, liver, and spleen, though these are less common. The key difference with AA amyloidosis is that it is driven by another disease process, so controlling that underlying condition is essential to stopping amyloid production.[3][5]

Once amyloid deposits begin forming in any organ, they tend to build up faster than the body can break them down naturally. This creates a cycle where the deposits interfere with normal organ structure and function, leading to symptoms and complications. The body’s immune system has limited ability to clear these abnormal protein deposits on its own, which is why medical intervention is necessary to halt the disease progression.[6]

Possible Complications of Amyloidosis

Amyloidosis can lead to a wide range of complications because the amyloid deposits can affect virtually any organ system in the body. These complications often develop gradually as more amyloid accumulates, but they can sometimes appear suddenly and create medical emergencies. Understanding what complications might occur helps you and your care team watch for warning signs and respond quickly.[1][2]

Heart complications are among the most serious concerns with amyloidosis. When amyloid builds up in the heart, it causes the heart muscle to become thick and stiff, a condition known as restrictive cardiomyopathy. This stiffness prevents the heart from filling properly with blood between beats, reducing how much blood the heart can pump out to the body. People may develop heart failure, experiencing severe shortness of breath, extreme fatigue, and fluid retention that causes swelling in the legs, ankles, and abdomen. Amyloid deposits can also disrupt the heart’s electrical system, leading to irregular heart rhythms called arrhythmias. Some of these rhythm problems can be life-threatening and may cause fainting, dizziness, or even sudden cardiac arrest.[1][2]

Kidney complications develop when amyloid deposits damage the tiny filtering units in the kidneys. This causes protein to leak into the urine, a condition called proteinuria. As more amyloid accumulates, kidney function deteriorates, and waste products that should be filtered out begin to build up in the blood. This can progress to complete kidney failure, requiring dialysis or kidney transplantation to survive. Kidney involvement is particularly common in AL and AA types of amyloidosis. People with kidney amyloidosis may notice foamy urine, swelling in their feet and legs, and feeling generally unwell as toxins accumulate in their body.[1][3]

Nervous system complications occur when amyloid deposits affect the nerves. This can cause peripheral neuropathy, where the nerves in the hands and feet become damaged. People experience tingling, numbness, burning pain, or a sensation like pins and needles in their extremities. The damage can also affect the nerves’ ability to sense temperature properly, increasing the risk of burns or frostbite without realizing it. When amyloidosis affects the autonomic nervous system, which controls automatic body functions, it can cause problems with blood pressure regulation, leading to severe dizziness or fainting when standing up. It can also affect digestion, causing severe constipation or diarrhea, and may interfere with bladder control.[1][15]

Digestive system complications can be particularly troublesome. Amyloid deposits in the digestive tract can slow down the movement of food through the system, causing severe constipation, nausea, and feeling full after eating only small amounts of food. Some people experience the opposite problem, with frequent diarrhea. Amyloid in the tongue can cause it to become enlarged, a condition called macroglossia, which can make speaking, swallowing, and even breathing more difficult. If the liver or spleen become infiltrated with amyloid, they may become enlarged, causing discomfort in the abdomen.[1][5]

Blood-related complications include abnormal bleeding. Amyloid can interfere with blood clotting proteins, and some people develop a condition where small blood vessels in the skin leak blood, causing purplish patches called purpura, especially around the eyes. This is a characteristic sign of AL amyloidosis. More seriously, some patients may develop significant bleeding problems that can be dangerous during surgery or after injuries.[1][2]

Musculoskeletal complications can include carpal tunnel syndrome, where amyloid deposits compress the nerve that runs through the wrist, causing hand numbness and weakness. Some people develop joint pain or stiffness, and amyloid can deposit in bones and soft tissues, causing pain and limiting movement. These symptoms can sometimes appear years before amyloidosis is diagnosed, particularly in ATTR amyloidosis.[17]

⚠️ Important
Many complications of amyloidosis develop gradually and can be mistaken for normal aging or other conditions. If you notice new or worsening symptoms, always report them to your healthcare team promptly. Early intervention can often prevent complications from becoming more severe and may improve your quality of life significantly.

Impact of Amyloidosis on Daily Life

Living with amyloidosis affects far more than just your physical health. The disease can touch every aspect of your daily life, from your ability to work and care for yourself to your relationships, emotional well-being, and future plans. Understanding these impacts and learning how to adapt can help you maintain the best possible quality of life despite the challenges.[14][20]

Physically, amyloidosis often brings profound fatigue that goes beyond normal tiredness. This exhaustion can make even simple tasks feel overwhelming. You might find that activities you once did easily—like climbing stairs, carrying groceries, or playing with grandchildren—now leave you breathless and exhausted. This isn’t laziness or weakness; it’s a real symptom of your organs not functioning as efficiently as they should. Many people find they need to pace themselves throughout the day, taking rest breaks and prioritizing which activities are most important to them.[1][15]

Your work life may need significant adjustments. Some people with amyloidosis continue working, especially if their symptoms are mild or well-controlled with treatment. However, you may need to take frequent time off for medical appointments, treatments, and hospital stays. Some employers can be flexible with working conditions, perhaps allowing you to work from home, reduce your hours, or take on less physically demanding responsibilities. However, it’s also possible that your illness may eventually prevent you from working altogether. In many countries, you may be eligible for disability benefits or other forms of financial assistance if you can no longer work. It’s worth exploring what support is available in your location.[14]

Daily self-care tasks that most people take for granted can become challenging. If neuropathy affects your hands, you might struggle with buttons, zippers, or handling small objects. Numbness in your feet can affect your balance and increase your risk of falls. Some people need to make modifications to their home environment, such as installing grab bars in the bathroom, using adaptive equipment for dressing, or arranging for help with housework and meal preparation. These adjustments aren’t admissions of defeat—they’re practical solutions that help you stay safe and independent.[15][20]

Social life and relationships often change when you’re living with a serious illness. You might need to cancel plans when you’re not feeling well, which can be frustrating for both you and your friends or family. Some people find that others don’t understand why they look fine but can’t do certain activities, which can lead to feelings of isolation or being judged. It’s important to communicate openly with the people in your life about what you’re experiencing. True friends and family will want to understand and support you, even if they can’t fully grasp what you’re going through.[20]

Your diet may need to change, especially if amyloidosis is affecting your kidneys or digestive system. You might need to limit salt to reduce fluid retention and swelling, reduce protein intake if your kidneys are struggling, or adjust your eating patterns if you’re experiencing nausea or early fullness. Working with a registered dietitian can help you develop a nutrition plan that meets your body’s needs while still including foods you enjoy. Staying well-hydrated is generally important, though you should follow your doctor’s specific recommendations, as some people with heart or kidney involvement may need to limit fluids.[15][20]

Physical activity and exercise require a careful balance. While staying active is generally beneficial and can help maintain your strength, heart function, and overall wellbeing, you need to be realistic about what your body can handle. This is particularly true for cardiac amyloidosis, where too much exertion can be dangerous. Your healthcare team can advise you on what level of activity is safe and appropriate for your situation. Even gentle activities like walking or light stretching can be helpful if done within your limits.[20]

Emotionally, living with amyloidosis can be a rollercoaster. It’s completely normal to feel scared, angry, sad, or frustrated about your diagnosis and how it’s affecting your life. Many people with amyloidosis struggle with anxiety or depression, particularly when facing uncertainty about the future or dealing with significant limitations. Mental health is just as important as physical health, and seeking support from a counselor, therapist, or support group can make a real difference. Connecting with other people who have amyloidosis, either online or in person, can be particularly valuable because they truly understand what you’re going through in a way that others might not.[20]

Managing your medical care becomes a significant part of your life. You’ll likely have frequent appointments with multiple specialists, regular blood tests and monitoring, and complex medication schedules. Keeping organized records of your medical history, test results, and treatments can help you feel more in control and ensures that all your healthcare providers have the information they need. Many people find it helpful to bring a family member or friend to important appointments to help remember information and ask questions.[15]

Despite all these challenges, many people with amyloidosis find ways to adapt and maintain meaningful, fulfilling lives. Focusing on what you can do rather than what you can’t, celebrating small victories, staying connected with loved ones, and finding moments of joy in each day can all help. Your life may look different than you planned, but it can still hold purpose, love, and happiness.[17][20]

How Family Can Support Participation in Clinical Trials

For families navigating an amyloidosis diagnosis, understanding clinical trials and how they might benefit your loved one is an important part of supporting their care. Clinical trials are research studies that test new treatments, diagnostic methods, or ways of managing disease. They play a crucial role in advancing amyloidosis care and may offer access to promising therapies that aren’t yet widely available.[9][13]

Clinical trials are particularly relevant for amyloidosis because it’s a rare disease, and research is constantly evolving. Many of the treatments that are now standard care for amyloidosis were once only available through clinical trials. Trials are currently investigating new medications, combinations of existing drugs, advanced therapies like CAR T-cell therapy targeting specific proteins involved in the disease process, and treatments for relapsed or treatment-resistant amyloidosis. For some patients, participating in a clinical trial may be the best or only way to access certain cutting-edge treatments.[9][13]

As a family member, one of the most valuable things you can do is help your loved one learn about clinical trial options. This starts with asking their healthcare team whether there are any trials they might be eligible for. Doctors who specialize in amyloidosis are usually aware of relevant studies and can discuss whether participating might make sense for your family member’s specific situation. You can also research trials independently through registries like ClinicalTrials.gov or through amyloidosis patient advocacy organizations, which often maintain information about ongoing studies.[11][16]

Understanding what participation involves is crucial. Clinical trials have specific eligibility criteria—requirements about age, disease type, stage of disease, previous treatments, and other factors. Not everyone will qualify for every trial. The trial protocol will outline what treatments or procedures will be involved, how often visits are required, what monitoring will be done, and what the potential risks and benefits are. Helping your loved one understand these details can make the decision less overwhelming. You might offer to attend appointments where trials are discussed, take notes, and help formulate questions.[16]

Important questions to ask about any clinical trial include: What is the trial trying to find out? What treatment would my loved one receive, and how does it compare to standard treatment? What are the possible side effects or risks? How long does the trial last? How often are visits required, and where will they take place? Will participation cost anything? What happens after the trial ends? Can my loved one leave the trial if they wish? Getting clear answers to these questions helps everyone make an informed decision.[11][16]

Practical support can make a huge difference in whether someone can participate in a clinical trial. Many trials require frequent visits to specific medical centers, which may involve significant travel. Family members can help by providing transportation, accompanying the patient to appointments, helping manage the logistics of travel and accommodation if the trial is far from home, and assisting with any additional monitoring or medication schedules required by the study protocol. This practical help can transform a seemingly impossible commitment into something manageable.[11]

Emotional support throughout the trial process is equally important. Deciding to join a clinical trial can bring up complicated feelings—hope about accessing new treatments, but also anxiety about the unknown, fear about possible side effects, or guilt about “being experimented on.” Family members can provide reassurance, remind the patient that they’re helping advance medical knowledge that may help others, and simply listen to their concerns without judgment. If the patient experiences side effects or challenges during the trial, being there to support them through it matters enormously.[20]

It’s important for families to understand that joining a clinical trial is always voluntary, and the patient has the right to withdraw at any time without affecting their regular medical care. The decision should never feel pressured. Some people find great meaning in contributing to research that may help future amyloidosis patients, while others prefer to stick with established treatments. Both choices are valid, and the decision should be based on the patient’s values, circumstances, and medical situation.[16]

Insurance coverage for clinical trials can be complex, and this is another area where family members can help. In many countries, health insurance must cover the standard care portions of clinical trial treatment, though coverage policies vary. Understanding what costs are covered by the trial, what insurance will pay, and what might be out-of-pocket expenses is important before making a commitment. Don’t hesitate to ask the trial coordinators and your insurance company detailed questions about financial responsibility.[11]

Finally, families should be aware that clinical trial participation involves additional responsibilities beyond regular medical care. This might include keeping detailed diaries of symptoms or side effects, adhering strictly to medication schedules, and attending all required follow-up visits. Family members can help ensure these commitments are met, which is crucial for both the patient’s safety and the scientific validity of the study. Supporting your loved one through a clinical trial can be demanding, but it’s also an opportunity to be actively involved in their care in a meaningful way.[9]

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Daratumumab plus hyaluronidase (in combination with cyclophosphamide, bortezomib, and dexamethasone) – First FDA-approved treatment specifically for newly diagnosed AL amyloidosis, targeting abnormal plasma cells that produce amyloid proteins
  • Cyclophosphamide – Chemotherapy agent used as part of combination regimens to reduce abnormal plasma cell production in AL amyloidosis
  • Bortezomib (Velcade) – Chemotherapy medication used in combination therapy to target the plasma cells producing abnormal light chain proteins
  • Dexamethasone – Corticosteroid used in combination treatment regimens for AL amyloidosis

Ongoing Clinical Trials on Amyloidosis

  • Study on How Tafamidis is Absorbed in the Blood of Healthy Adults with Transthyretin Amyloid Cardiomyopathy

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Belgium
  • Study of Belantamab Mafodotin for Patients with Relapsed or Refractory AL Amyloidosis

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Greece Italy The Netherlands
  • Study on the Effectiveness of Isatuximab, Pomalidomide, and Dexamethasone for Patients with AL Amyloidosis Not Responding Well to Previous Treatments

    Not recruiting

    1 1 1
    Investigated diseases:
    France

References

https://www.mayoclinic.org/diseases-conditions/amyloidosis/symptoms-causes/syc-20353178

https://my.clevelandclinic.org/health/diseases/23398-amyloidosis

https://www.webmd.com/cancer/lymphoma/amyloidosis-symptoms-causes-treatments

https://amyloidosis.org/facts/

https://www.ncbi.nlm.nih.gov/books/NBK470285/

https://www.ucl.ac.uk/medical-sciences/divisions/national-amyloidosis-centre/information-patients/helping-you-understand-amyloidosis

https://www.mayoclinic.org/diseases-conditions/amyloidosis/diagnosis-treatment/drc-20353183

https://my.clevelandclinic.org/health/diseases/23398-amyloidosis

https://pmc.ncbi.nlm.nih.gov/articles/PMC11991823/

https://www.fredhutch.org/en/diseases/amyloidosis/treatment.html

https://arci.org/patients-and-caregivers/new-to-amyloidosis/

https://emedicine.medscape.com/article/1093258-treatment

https://www.mskcc.org/news/car-cell-therapy-for-light-chain-al-amyloidosis-achieves-strong-results

https://www.mpeurope.org/what-we-do/educational-resources/qas/living-with-al-amyloidosis/

https://www.emea.jnjwithme.com/en/blood-cancer/amyloidosis/living-with-al-amyloidosis

https://arci.org/patients-and-caregivers/new-to-amyloidosis/

http://www.cardiosmart.org/topics/cardiac-amyloidosis/living-with-cardiac-amyloidosis

https://www.mayoclinic.org/diseases-conditions/amyloidosis/diagnosis-treatment/drc-20353183

https://my.clevelandclinic.org/health/diseases/23398-amyloidosis

https://www.myamyloidosisteam.com/resources/living-with-amyloidosis

https://www.fredhutch.org/en/diseases/amyloidosis/treatment.html

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.nibib.nih.gov/science-education/science-topics/rapid-diagnostics

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

FAQ

How long does it typically take to get diagnosed with amyloidosis?

Diagnosis is often significantly delayed because symptoms mimic more common conditions. Research shows that around 70% of patients don’t receive their diagnosis until more than a year after symptoms begin, and up to 20% may not be correctly diagnosed for two years or longer. Almost one-third of people visit over five physicians before getting the correct diagnosis.

Can amyloidosis be inherited from parents?

Some types of amyloidosis are hereditary, particularly certain forms of ATTR amyloidosis where a genetic mutation causes the body to produce abnormal transthyretin protein. However, not everyone who inherits the gene mutation will develop the disease, and among those who do, progression can be very slow. AL amyloidosis and AA amyloidosis are not inherited conditions.

Will I be able to continue working after an amyloidosis diagnosis?

Many people continue working after diagnosis, especially if symptoms are mild or well-controlled. However, you may need time off for tests, treatments, and hospital stays. The ability to work depends on your type of employment, symptom severity, and how physically demanding your job is. Some employers offer flexible arrangements like reduced hours or remote work. If working becomes impossible, you may be eligible for disability benefits.

Is the type of amyloidosis I have important for treatment?

Yes, identifying the exact type of amyloidosis is extremely important because treatment varies greatly between types. AL amyloidosis requires treatments targeting abnormal plasma cells, while ATTR amyloidosis may respond to medications that stabilize the transthyretin protein. AA amyloidosis treatment focuses on controlling the underlying inflammatory condition. Knowing which protein is forming amyloid deposits guides all treatment decisions.

What dietary changes should I make with amyloidosis?

Dietary needs vary depending on which organs are affected. If amyloidosis involves your kidneys, you may need to reduce salt and protein intake. Generally, eating a healthy diet and staying well-hydrated (typically 2-3 liters of water daily unless your doctor advises otherwise) is recommended. A registered dietitian can help create a personalized nutrition plan that addresses your specific organ involvement and overall health needs.

🎯 Key takeaways

  • Amyloidosis is a rare group of diseases where misfolded proteins clump together and deposit in organs, potentially causing serious damage throughout the body.
  • The type of protein involved determines which kind of amyloidosis you have, and accurate diagnosis is crucial because treatments differ significantly between types.
  • Diagnosis is often delayed because symptoms like fatigue, shortness of breath, and swelling can mimic many more common conditions, with many patients seeing multiple doctors over one to two years before getting the correct diagnosis.
  • Healthcare providers can now stop abnormal protein production in several types of amyloidosis, and your body’s immune system may help remove existing deposits, potentially improving organ function.
  • Prognosis varies greatly depending on the specific type, which organs are affected, how early treatment begins, and individual response to therapy.
  • Without treatment, amyloid proteins continue accumulating in organs, progressively interfering with their function and leading to complications like heart failure, kidney failure, or severe nerve damage.
  • Living with amyloidosis requires adapting many aspects of daily life, from work arrangements to diet, physical activity, and self-care tasks, but people can still lead meaningful lives with proper management and support.
  • Clinical trials offer access to promising new treatments and advance medical knowledge that may help future patients, with family support being crucial in making participation possible.